Terms ending in 2031
Every in-force patent on Mesoblast, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,456,451 | Protease-Resistant Mutants of Stromal Cell Derived FACTOR-1 in the Repair of Tissue Damage In force · High confidence | Mesoblast International Sàrl | In force | High confidence | |
| US 10,105,394 | Method of Treating Graft Versus Host Disease In force · Medium confidence | Mesoblast, Inc. | In force | Medium confidence | |
| US 10,849,932 | Method of Treating Graft Versus Host Disease In force · Medium confidence | Mesoblast, Inc. | In force | Medium confidence | |
| US 8,894,972 | Method for Treating or Preventing a Pancreatic Dysfunction In force · High confidence | Mesoblast, Inc. | In force | High confidence | |
| US 9,388,385 | Methods for Treating Obesity And/Or Metabolic Syndrome In force · High confidence | Mesoblast, Inc. | In force | High confidence | |
| US 10,159,696 | Methods for Treating Obesity And/Or Metabolic Syndrome In force · High confidence | Mesoblast, Inc. | In force | High confidence | |
| US 9,828,586 | Enhanced MSC Preparations In force · Medium confidence | Mesoblast International SARL | In force | Medium confidence | |
| US 9,963,678 | Enhanced MSC Preparations In force · Low confidence | Mesoblast International SARL | In force | Low confidence | |
| US 11,708,560 | Enhanced MSC Preparations In force · Low confidence | Mesoblast International Sàrl | In force | Low confidence | |
| US 12,410,405 | Enhanced MSC Preparations In force · High confidence | Mesoblast International Sàrl | In force | High confidence | |
| 1 more term end in 2031 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.